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Eukaryotic Okazaki fragment maturation requires complete
removal of the initiating RNA primer before ligation occurs.
Polymerase  (Pol ) extends the upstream Okazaki fragment
and displaces the 5-end of the downstream primer into a single
nucleotide flap, which is removed by FEN1 nuclease cleavage.
This process is repeated until all RNA is removed. However, a
small fraction of flaps escapes cleavage and grows long enough
to be coatedwithRPAand requires the consecutive action of the
Dna2 and FEN1 nucleases for processing. Here we tested
whether RPA inhibits FEN1 cleavage of long flaps as proposed.
Surprisingly, we determined that RPA binding to long flaps
made dynamically by polymerase  only slightly inhibited FEN1
cleavage, apparently obviating the need for Dna2. Therefore, we
asked whether other relevant proteins promote long flap cleav-
age via theDna2pathway.ThePif1helicase, implicated inOkazaki
maturation from genetic studies, improved flap displacement and
increased RPA inhibition of long flap cleavage by FEN1. These
results suggest thatPif1accelerates long flapgrowth, allowingRPA
to bind before FEN1 can act, thereby inhibiting FEN1 cleavage.
Therefore, Pif1 directs long flaps toward the two-nuclease path-
way, requiring Dna2 cleavage for primer removal.
During eukaryotic DNA replication, the lagging strand is
replicated via synthesis and maturation of Okazaki fragments.
These fragments are short stretches of DNA that are joined to
generate a continuous strand (1). Each fragment is initiated
when DNA polymerase /primase (Pol )3 makes an RNA/
DNA primer, synthesizing 10 nucleotides (nt) of RNA fol-
lowed by 10–20 nt of DNA (2). The primer is then extended by
a complex of DNA polymerase  (Pol ), the sliding clamp,
proliferating cell nuclear antigen (PCNA), and the clamp
loader, replication factor C (RFC). When Pol  encounters the
5-end of the downstreamOkazaki fragment, it displaces it into
a flap. Cleavage of the flap by nucleases generates a nick, which
is subsequently sealed byDNA ligase I to form continuous dou-
ble-stranded DNA (3, 4).
One pathway for cleavage of the flap employs flap endonu-
clease 1 (FEN1). FEN1 is a single-strand, structure-specific
endonuclease that enters the 5-end of the flap and tracks to the
base for cleavage (3, 5, 6). Following displacement of a short
flap, less than about 12 nt, by Pol , FEN1 cleaves leaving a nick,
the substrate forDNA ligase I (7–9). Because theRNA initiating
the Okazaki fragments is 10 nt in length, short flaps com-
posed entirely of RNA are first displaced by Pol . This does not
obstruct FEN1, which is active on RNA (10, 11). In addition,
displacement and cleavage occurs mostly within the first 25 nt
of the downstream fragment, sufficient to remove the entire
RNA/DNAprimer, which is20–30 nt in length (11). Previous
biochemical studies demonstrated that primarily short flaps are
cleaved by FEN1. It is likely that in vivo a series of short succes-
sive displacements by Pol  and cleavages by FEN1 are effective
for removal of the entire initiating RNA/DNAprimer (7–9, 11).
However, although Pol  and FEN1 appear to be designed to
keep flaps short, reconstitutions in vitro demonstrate the cre-
ation of some long flaps,20–30 nt in length (11). Biochemical
results suggest that once flaps achieve lengths in the range of 30
nt they can be bound by RPA, which inhibits FEN1 cleavage.
RPA-coated flaps must then be processed by an alternative
pathway.
This second pathway is proposed to require Dna2 (13). Dna2
is an ATP-dependent helicase and a single-stranded DNA-spe-
cific endonuclease (14, 15). The endonuclease activity requires
tracking from the 5-end of a flap and is stimulated by RPA (13,
16, 17). Because the specificity of Dna2 does not allow for cleav-
age at the base of a flap to generate a nick, the terminal Dna2
product is a short flap (17). The remaining flap is too small to be
bound byRPA, so it can be cleaved by FEN1 to generate the nick
for ligation (13, 15). In this way, the properties of the nucleases
and RPA order the reactions with Dna2 cleaving first and FEN1
second.
The proposed coordinated function of Dna2 and FEN1 is
supported by other results in which they have been shown to
interact physically through co-immunoprecipitation (18) and
genetically through deletion studies in Saccharomyces cerevi-
siae (18, 19). Deletion ofDNA2 is lethal in S. cerevisiae (20, 21).
Moreover, the dna2-1 mutant, which has impaired nuclease
activity, is synthetically lethal with the rad27, which has
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impaired FEN1 flap-cleavage activity (18). However, dna2-1
nucleasemutants show a temperature-sensitive phenotype that
is suppressed by overexpression of FEN1 (18, 19). Likewise, the
temperature-sensitive phenotype of rad27 mutants is sup-
pressed by overexpression of Dna2 (18).
In addition, in S. cerevisiae, recent deletion studies highlight
the importance of Dna2 in replication and implicate the Pif1
helicase in maturation of Okazaki fragments (22). Pif1 is a 5-3
helicase conserved from yeast to humans (23, 24). Budd and
colleagues (22) found that pif1 rescued the lethality of dna2.
Also, pif1 rescued the temperature-sensitive phenotype of the
dna2-1 mutant. They proposed that Pif1 creates a need for
Dna2 by promoting formation of long flaps. Although deletion
of PIF1 rescued the dna2-1 mutant, the mutant strain had
residual phenotypic defects consistent with disruptions in rep-
lication. The additional deletion of POL32 in the dna2-1 pif1
strain suppressed these defects (22). Pol32 is the subunit of Pol
 that binds to PCNA, and deletion of this subunit has been
shown to limit some of the strand-displacement activity of Pol 
(25, 26). The phenotype of the triple mutant dna2-1 pif1
pol32 further supports the hypothesis that Pif1 promotes long
flap formation (22). By deleting bothPIF1 andPOL32, it is likely
that flap displacement lengths are shorter and flaps do not bind
RPA, a situation that eliminates the need for Dna2 cleavage.
Similar to Pif1 in S. cerevisiae, it was previously shown that
Pfh1, the Pif1 ortholog in Schizosaccharomyces pombe, has an
interaction with Dna2 (27). Pfh1 is essential in S. pombe (28).
However, mutation of pfh1 suppresses the temperature-sensi-
tive phenotype of dna2 mutants. Moreover, mutations in pfh1
and cdc27, the PCNA-interacting subunit of Pol  in S. pombe,
are synthetically lethal (27). These results suggest that Pfh1,
Dna2, and Pol  participate in similar pathways in yeast, pre-
sumably Okazaki fragment maturation.
Together the biochemical and genetic data suggest that both
FEN1 and Dna2 are involved in the processing of flaps to
remove the RNA/DNA primer initiating Okazaki fragments (3,
4, 29). However, it has not been clearly established how the
presence of RPA and Pif1 may affect the directing of flaps into
either the FEN1 cleavage pathway or the two-nuclease pathway
requiring Dna2. Through reconstitution studies in vitro with
purified proteins from S. cerevisiae, we set out to examine the
influence of RPA and Pif1 on the length of flap displacement
and subsequent cleavage by FEN1.
EXPERIMENTAL PROCEDURES
Materials—Oligonucleotides were synthesized by either
Midland Certified Reagents Company (Midland, TX) or Inte-
grated DNA Technologies (Coralville, IA). Radionucleo-
tides [-32P]ATP and [-32P]dCTP were purchased from
PerkinElmer Life Sciences. Polynucleotide kinase, the Klenow
fragment of Escherichia coli DNA polymerase I, and streptavi-
din were obtained from Roche Applied Science. All other
reagents were the best commercially available.
Enzyme Expression and Purification—S. cerevisiae wild-type
Pol  (Pol -wt) (25) and 3-5 exonuclease-deficient Pol  (Pol
-01) (9, 25) were overexpressed and purified from S. cerevisiae
as previously described. S. cerevisiae RFC was overexpressed
and purified from E. coli as previously described (30). S. cerevi-
siae Rad27 (31) (referred to as FEN1) and PCNA (11) were
cloned into the T7 expression vector pET-24b (Novagen/EMD
Biosciences, Madison, WI), expressed in E. coli BL21(DE3)
codon plus strain (Stratagene and Novagen/EMD Biosciences,
respectively) and purified as previously described, resulting in a
recombinant protein with a C-terminal His6 tag. S. cerevisiae
Pif1 was cloned into the pET-28b bacterial expression vector
(Novagen/EMD Biosciences), expressed in the E. coli Rosetta
strain (Novagen/EMD Biosciences), and purified as previously
described resulting in recombinant protein with an N-terminal
His6 tag (32).
Oligonucleotide Substrates—Substrates were designed to
resembleOkazaki fragment processing intermediates using oli-
gonucleotide primers. The primer sequences are listed in Table
1. Primers D1, D2, and D3 were radiolabeled on the 5-end with
[-32P]ATP and polynucleotide kinase. Primer D1 was radiola-
beled on the 3-end by annealing a 20-nt labeling template with
a 5-GCTA overhang to the 3-end of the primer and incorpo-
rating dC using [-32P]dCTP and the Klenow polymerase.
Radiolabeled primers were fractionated by electrophoresis on a
15% 7Murea polyacrylamide gel and then purified. The primers
were then annealed into substrates in a 1:2:4 ratio of labeled
downstreamprimer to template to upstreamprimer. Substrates
were annealed by combining corresponding primers in a buffer
TABLE 1
Oligonucleotide sequences
Primer Length Sequence
nt
Upstream (5-3)
U1 20 GTCCACCCGACGCCACCTCC
U2 44 GTCCACCCGACGCCACCTCCTGCCTTCAATGTGCTGGGATCCTA
Downstream (5-3)
D1 60 AGACGAATTCCGGATACGACGGCCAGTGCCGACCGTGCCAGCCTAAATTTCAATCCACCC
D2a 59 GACGAATTCCGGATACGACGGCCAGTGCCGACCGTGCCAGCCTAAATTTCAATCCACCC
D3b 59 GACGAATTCCGGATACGACGGCCAGTGCCGACCGTGCCAGCCTAAATTTCAATCCACCC
Template (3-5)
T1 42 CAGGTGGGCTGCGGTGGAGGGTCGGATTTAAAGTTAGGTGGG
T2 51 CAGGTGGGCTGCGGTGGAGGGCTGGCACGGTCGGATTTAAAGTTAGGTGGG
T3 60 CAGGTGGGCTGCGGTGGAGGCCGGTCACGGCTGGCACGGTCGGATTTAAAGTTAGGTGGG
T4c 110 CAGGTGGGCTGCGGTGGAGGACGGAAGTTACACGACCCTAGGATGTTGGTTCTGCTTAAGG
CCTATGCTGCCGGTCACGGCTGGCACGGTCGGATTTAAAGTTAGGTGGG
a Underline indicates the RNA segment.
b Underline and italicized indicates the 2-O-methylated RNA segment.
c Template T4 is biotinylated at both the 5- and 3-ends.
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containing 50 mM Tris-HCl, pH 8.0, 50 mM NaCl, and 1 mM
dithiothreitol, heating at 95 °C for 5 min, transferring to 70 °C,
and cooling to room temperature.
Three sets of substrates were used in the following experi-
ments. One set was used to examine FEN1 cleavage following
strand displacement by Pol . These contained a 44-nt
upstream primer and a 60-nt downstream primer annealed to
the 3- and 5-ends, respectively, of a 110-nt template and will
be referred to as the standard-44 substrate. A second set of
substrates contained the same 44-nt upstream primer and
110-nt template of the standard-44 substrate, except the down-
stream primer was 59-nt in length and initiated by either a
single nucleotide of RNA or a single nucleotide of 2-O-meth-
ylated RNA. The annealed substrates will be referred to as the
RNA substrate or methylated RNA substrate, respectively. The
third set of substrates were fixed double-flaps, in which an
upstream 1-nt 3 tail complementary to the template overlaps
with a 5 flap on the downstream primer, and was used for
examining FEN1 cleavage. The fixed double-flap substrates
contained a 20-nt upstream primer and 60-nt downstream
primer annealed to the 3- and 5-ends, respectively, of varying
length templates, 60, 51, or 42 nt, forming 19-, 28-, or 37-nt
double-flaps, respectively. The sequence of the fixed double-
flap substrates is the same on the flap and at the base of the flap
as when flaps of 19, 28, or 37 nt are formed from displacement
of the downstream primer on the standard-44 substrates. Spe-
cific substrates used are indicated in the figure legends and
depicted above the figures.
Enzyme Assays—For strand-displacement reactions, 5 fmol
of labeled biotinylated substratewas incubatedwith 500 fmol of
streptavidin for 20 min on ice, prior to starting each reaction.
The streptavidin complexes with the biotinylated template
strand and blocks the ends of theDNA, providing a substrate on
which RFC must load PCNA. In the figures, substrates are
depicted without blocked ends for simplicity. Substrate was
then incubated with 23 fmol of Pol -wt or Pol -01, 25 fmol
each of PCNA and RFC, 20 fmol of FEN1, 100 fmol of RPA, and
25, 50, or 100 fmol of Pif1 for 10 min at 30 °C in a total volume
of 20 l of reaction buffer. Reaction buffer contained 50 mM
Tris-HCl, pH 7.5, 2 mM dithiothreitol, 25 g/ml bovine serum
albumin, 0.5 mM MgCl2, 1 mM ATP, 50 M dNTPs, and 75 mM
NaCl. Reactions were stopped by addition of 10l of 2 termi-
nation dye (90% formamide (v/v), 10 mM EDTA with 0.01%
bromphenol blue and xylene cyanole) and heating at 95 °C for 5
min. Products were separated by electrophoresis on a 15% 7 M
urea polyacrylamide gel. The gel was dried, scanned using a GE
Healthcare PhosphorImager, and analyzed using Image Quant
version 1.2 software. All assays were repeated at least in tripli-
cate with a representative gel shown in the figure.
For the fixed double-flap cleavage reactions, 5 fmol of sub-
stratewas incubatedwith 500 fmol of streptavidin for 20min on
ice, prior to the start of each reaction. Although the substrates
were not conjugated with biotin, streptavidin was included to
control for any effects of free streptavidin in the reaction mix-
ture. Substrate was then incubated with 20 fmol of FEN1 and
50, 100, or 200 fmol of RPA for 10min at 30 °C in a total volume
of 20 l of reaction buffer (same as above). Reactions were
stopped, electrophoresed, and analyzed as directed above.
Cleavage Product Distribution Analysis—For each lane of
interest, the cleavage product bands were identified and corre-
lated with flap length. Using ImageQuant software, peak pixel
intensities of each gel lane were obtained and matched with a
corresponding cleavage product band and flap length. Pixel
intensities of the cleavage bands for FEN1 cleavage alone were
subtracted from the intensities of bands in reaction lanes con-
taining Pol , PCNA/RFC, and FEN1. The pixel intensity versus
the size of the flap cleavedwas graphed. Then, amoving average
trendline (period of three) was added to the graph to smooth
and more clearly indicate the trend of the data.
RESULTS
Because a fraction of the flapsmade in our Okazaki fragment
processing systemwas found to become long before cleavage by
FEN1 (11), we questioned whether RPA binding on these long
flaps is sufficient to effectively inhibit FEN1 cleavage, necessi-
tating cleavage by Dna2. First, we examined RPA inhibition on
flaps generated dynamically through strand displacement.
Additionally, based on the genetic evidence of a role for Pif1 in
Okazaki fragment maturation through its interaction with
Dna2 (22), we asked whether Pif1 stimulates formation of long
flaps, creating an additional need for the two-nuclease pathway.
Cleavage Product Distribution Indicates Both Short and Long
Products—During thematuration ofOkazaki fragments in vivo,
the flaps form through the dynamic process of strand-displace-
ment synthesis. Accordingly, FEN1 cleavage was investigated
during strand displacement on a substrate that simulates an
intermediate of Okazaki fragment maturation, the standard-44
substrate. This substrate contains an upstream primer and
downstream primer annealed to the 3- and 5-ends, respec-
tively, of an oligonucleotide template strand. Between the two
primers is a 6-nt gap allowing space for the polymerase to syn-
thesize, extending the upstream primer. FEN1 cleavage prod-
uct size wasmeasured during strand-displacement synthesis by
either Pol -wt or the 3-5 exonuclease-deficient Pol -01,
PCNA, and RFC on the standard-44 substrate (Fig. 1). For visu-
alization of the initial FEN1 cleavage products, the substrate
was radiolabeled on the 5-end of the downstream primer.
A 6-nt single-stranded DNA gap between the upstream and
downstream primers was specifically chosen for use in this
study. This 6-nt gap was expected to be too small for RPA bind-
ing (33).We also performed band shift experiments comparing
the level of RPA binding to a 6-nt gap substrate, a 30-nt gap
substrate, and a 60-nt length of single-strandedDNA.Results of
these experiments demonstrated that RPA is unable to bind the
6-nt gap substrate even at a concentration 2-fold higher than
used in the strand-displacement experiments (data not shown).
However, RPAdid bindwell to both the 30-nt gap substrate and
the single-stranded DNA. Consequently, the effects of RPA
binding are exclusively confined to the displaced flaps created
dynamically by Pol .
In the presence of PCNA, RFC, and either Pol -wt or Pol
-01, the maximum lengths of FEN1 cleavage products were
18 and 36 nt, respectively, for the two polymerases (Fig. 1A,
lanes 3 and 4, respectively). This is consistent with the product
lengths observed in our prior studies using a 30-nt gap-contain-
ing substrate, indicating that the length of the gap does not
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influence the results, because these gaps are filled in efficiently
by Pol  prior to strand-displacement synthesis (11). The longer
flaps created and cleaved in the presence of Pol -01 are under-
stood to derive from the increased strand-displacement activity
of 3-5 exonuclease-deficient Pol mutants (8, 9, 11).
Distribution of the FEN1 cleavage products accompanying
either Pol -wt or Pol -01 displacement synthesis was evalu-
ated. After quantitating the pixel intensities of the product
bands, band intensity versus the size of the flap cleaved was
graphed (Fig. 1B). The distribution revealed both a large popu-
lation of flaps cleaved at the short stage, up to 10 nt, and a
second small population of products cleaved from long flaps, up
to18 or 36 nt, following displacement by either the Pol -wt
or Pol -01, respectively. Similar to what was observed before
on the standard 30-nt gap-containing substrate (11), there was
a sharp peak distribution for the short cleavage products, and
the long cleavage product distribution was broad and flat (Fig.
1B). Similarity of the two-population distributions with differ-
ent substrates suggests that such distributions are generally
characteristic of FEN1 cleavage of Pol -displaced flaps.
FEN1Cleavage during FlapDisplacement IsOnlyModerately
Inhibited by RPA—Assessing the effects of RPA on FEN1 cleav-
age of long flaps is important for understanding the pathways of
flap removal. This is because the anticipated inhibition of FEN1
by RPA is expected to create the need for Dna2 and the two-
nuclease pathway. Cleavage by
FEN1wasmeasured in the presence
of Pol -01, PCNA, RFC, and
increasing amounts of RPA on the
standard-44 substrate radiolabeled
at the 5-end of the downstream
primer (Fig. 2). RPA did not notice-
ably affect strand displacement and
cleavage of flaps made in the pres-
ence of Pol -wt, which were less
than 20 nt (data not shown).
Because of its ability to generate
longer flaps than the Pol -wt (8, 9,
11), we anticipated that RPA inhibi-
tion of FEN1 would be more pro-
nounced with Pol -01. Therefore,
in this experiment, the exonuclease-
deficient Pol -01was used to exam-
ineRPA inhibition of FEN1 cleavage
following displacement.
RPAdid not significantly alter the
strand-displacement synthesis by
Pol -01 (data not shown). In exam-
ining FEN1 cleavage products
formed in the presence of Pol -01,
some moderate inhibitory effects
were discernible when increasing
amounts of RPA were added to the
reconstitution (Fig. 2, lanes 4–6
compared with lane 3). Percent
cleavage inhibition was determined
by comparing the amount of cleav-
age for reactions in the presence
versus absence of RPA. The amount of cleavage is defined as the
sum intensities of the cleavage product bands divided by the
sum intensities of the downstreamprimer and cleavage product
bands. To calculate percent inhibition, the value for cleavage
amount in the presence of RPA was divided by the value for
cleavage amount by FEN1 alone, subtracted from 1, and then
multiplied by 100. Relative to the total amount of cleavage, all
cleavage products greater than 28 nt long were diminished by
only 36% with addition of the highest concentration of RPA
(Fig. 2, lane 6). Likewise, all cleavage products of greater than 19
nt were decreased by only 38% (Fig. 2, lane 6). Cleavage prod-
ucts in the 28–37-nt size range were most sensitive with 48%
inhibition by RPA (Fig. 2, lane 6 compared with lane 3, brack-
eted region). Similarly, products in the 19–28-nt size range
were inhibited by 41% (Fig. 2, lane 6). This contrasts with prod-
ucts in the 10–19-nt size range, which were less susceptible to
RPA inhibition, displaying only 17% reduction at the highest
concentration of RPA (Fig. 2, lane 6). Greater inhibition of
cleavage that gave products greater than 19 nt is consistentwith
RPA binding more stably on single-stranded DNA greater than
30 nt long (33). However, based on the decrease of starting
substrate, comparing the overall amount of cleavage in the
absence and presence of RPA revealed similar cleavage levels,
indicating that RPAhas only amoderate effect on overall rate of
displacement and cleavage.
FIGURE 1. Cleavage product distribution indicates both short and long products. A, initial FEN1 cleavage
was assayed on the standard-44 substrate (U2:T4:D1) in the presence of PCNA/RFC and either Pol -wt, denoted
wt (lane 3), or Pol -01, denoted 01 (lane 4), as described under “Experimental Procedures.” The substrate is
depicted above the figure. The asterisk indicates location of radiolabel. B, the size of flap cleavage products
versus the intensity of theproductbandwasgraphedandmovingaverage trendline added, asdescribedunder
“Experimental Procedures.” The black line corresponds to the cleavage products for reconstitutions with Pol
-wt. The gray line corresponds to the products for reconstitutions with Pol -01.
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RPA Inhibits FEN1 Cleavage of Fixed Flap Substrates—Pre-
vious studies demonstrated that RPA binding, which blocks
FEN1 tracking to its cleavage site, was effective at inhibiting
FEN1 cleavage of long fixed flaps (13, 17). However, our results
showed only moderate inhibition of FEN1 cleavage by RPA on
the strand-displaced flaps. Consequently, we sought to verify
earlier results, and confirm the proper functionality of our RPA,
by examining the influence of RPA on FEN1 cleavage of fixed
flaps (Fig. 3). Fixed flap cleavage experiments with RPA and
FEN1 utilized a set of double-flap substrates that contained a
complementary 1-nt 3 tail overlapping with the 5 flap, creat-
ing a double flap. It was previously demonstrated through stud-
ies in vitro that this type of double flap is the preferred substrate
for FEN1 (31, 34, 35). During polymerase extension of the
3-end of the upstream Okazaki fragment and displacement of
the 5-end of the downstreamprimer, reversible unannealing of
FIGURE 2. FEN1 cleavage during flap displacement is moderately inhib-
ited by RPA. Initial cleavage by FEN1 was assayed on the standard-44 sub-
strate (U2:T4:D1) in the presence of PCNA/RFC, Pol -01, and increasing
amounts of RPA (50, 100, or 200 fmol) as described under “Experimental Pro-
cedures” (lanes 4–6). The substrate is depicted above the figure. Asterisk indi-
cates location of radiolabel.
FIGURE 3. RPA inhibits FEN1 cleavage of fixed flap substrates. A, cleavage
byFEN1wasassayed in thepresenceof increasingamountsof RPA (50, 100, or
200 fmol) asdescribedunder “Experimental Procedures.” The19-nt fixeddou-
ble-flap (U1:T3:D1) (lanes 1–5), 28-nt fixed double-flap (U1:T2:D1) (lanes 6–10),
and 37-nt fixed double-flap (U1:T1:D1) (lanes 11–15) are depicted above the
figure. The asterisk indicates location of radiolabel. B, the amount of RPA ver-
sus the percent cleavage inhibition was graphed for the 19-nt fixed double-
flap (blackboxes), 28-nt fixeddouble-flap (grayboxes), and37-nt fixeddouble-
flap (white boxes) for the gel in A. Percentages are indicated above the bar for
each substrate at eachconcentrationof RPA.C, cleavagebyFEN1wasassayed
in the presence of increasing amounts of RPA (50, 100, or 200 fmol) using the
37-nt fixed double-flap, as in A. In lanes 2–5, RPAwas added at the start of the
reaction and FEN1 was added after 5 min. In lanes 6–9, both FEN1 and RPA
were added at the start of the reaction, as in lanes 12–15 of A. In lanes 10–13,
FEN1 was added at the start of the reaction in the absence of Mg2, followed
by addition of both RPA andMg2 after 5min. Lane 14 contains FEN1 alone in
the absence of Mg2. The percent cleavage inhibition is shown under each
lane.
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the 3-end and realignment of the 5- and 3-ends may occur,
resulting in formation of a double flap (8, 12, 31). For this exper-
iment, the substrates contained 5 flaps 19, 28, and 37 nt in
length, all of which are long enough to bind RPA (33) and are
representative of the lengths of long flaps seen in strand-dis-
placement reconstitutions (11). Each substrate, depicted above
the figure, was radiolabeled at the 5-end of the downstream
primer to allow visualization of the flap cleavage product.
There were three significant FEN1 cleavage products seen
with each flap substrate, the major one representing cleavage
at the base of the 5 flap in the double-flap configuration (Fig.
3A). A minor product is one nucleotide longer and derives
from cleavage at the base of the 5 flap when the substrate has
equilibrated to a nick-flap configuration. A faint product is 1
nucleotide shorter, possibly representing a transient flap
configuration.
When increasing amounts of RPA were titrated into a reac-
tion with FEN1, the amount of FEN1 cleavage decreased sub-
stantially with the longer flaps (Fig. 3A, lanes 7–10 and 12–15),
but only marginal inhibition was observed with the 19-nt flap
that does not readily bind RPA (Fig. 3A, lanes 2–5). To quanti-
tate the level of this inhibition, we compared the cleavage for
reactions in the presence of RPA to the cleavage by FEN1 alone,
as described above. In the presence of the highest concentration
of RPA, the amount of FEN1 cleavage was inhibited to the
greatest extent on the long 28- and 37-nt flaps, with amaximum
inhibition of 93 and 92%, respectively (Fig. 3B). However, the
19-nt flap was markedly less susceptible to the effects of RPA,
with a maximum inhibition of only 13% (Fig. 3B). The extent of
inhibition seen here is consistent with previous biochemical
results (13, 17).
Evidently, FEN1 cleavage of the flaps created by the dynamic
process of strand displacement is less sensitive than cleavage of
fixed flaps to the inhibitory activity of RPA. To simulate a
dynamic competition, FEN1 cleavage of the 37-nt flap substrate
was assessed under conditions in which RPAwas added before,
with, or after the FEN1 (Fig. 3C). When FEN1 was added first,
the reaction lackedmagnesium, which was added later with the
RPA (Fig. 3C, lanes 10–13). This allowed the FEN1 to bind the
flap, but not cleave until the RPA was added, because FEN1 did
not cleave in the absence of magnesium (Fig. 3C, lane 14). Inhi-
bition by RPA was similar when it was added before or with
FEN1 (Fig. 3C, lanes 2–5 and 6–9, respectively), but consider-
ably less when FEN1 was added first (Fig. 3C, lanes 10–13).
Such an outcome is consistent with the interpretation that a
growing flap can acquire FEN1 before it is long enough for
stable binding by RPA.
Pif1 Improves Flap Displacement and Promotes RPA Inhibi-
tion of FEN1 Cleavage—In S. cerevisiae, pif1 rescues the
lethality of dna2 suggesting that Pif1 creates a need for Dna2,
possibly by promoting the formation of long flaps (22). These
genetic studies support a role for Pif1 inOkazaki fragmentmat-
uration, specifically in the two-nuclease primer removal path-
way. To investigate this potential role, we asked whether Pif1
stimulates strand displacement and subsequent FEN1 cleavage
of long flaps. Additionally, because RPA was inefficient at
inhibiting FEN1 cleavage on long displaced flaps, we ques-
tioned whether the action of Pif1 would exacerbate RPA inhi-
bition of FEN1 cleavage, augmenting the need for flap cleavage
by Dna2. Again using the standard-44 substrate radiolabeled at
the 5-end of the downstream primer in reconstitution assays,
the effects of Pif1 and RPA on initial FEN1 cleavages following
displacement by Pol -wt were examined (Fig. 4). With Pol
-wt, PCNA, and RFC, the maximum length of FEN1 cleavage
products was 18 nt (Fig. 4, lane 3), consistent with previous
results (11). When increasing amounts of Pif1 were added, the
maximum cleavage product length increased to33 nt (Fig. 4,
lanes 4–6). Moreover, the density of longer products,28–33
nt in length notably increased (Fig. 4, lanes 4–6 compared with
lane 3, bracket region). These results show that addition of Pif1
improves the displacement and cleavage of longer flaps. The
levels of Pol  synthesis were mildly stimulated by the presence
of Pif1 (data not shown), suggestive that the polymerase and
helicase cooperate in strand displacement.
Strand lengths of 28–33 nt had previously been reported to
allow stable RPA binding (33). Because of this, we wanted to
FIGURE 4. Pif1 improves flap displacement and promotes RPA inhibition
of FEN1 cleavage. Initial cleavage by FEN1 was assayed on the standard-44
substrate (U2:T4:D1) in the presence of PCNA/RFC, Pol -wt, and increasing
amounts of Pif1 (25, 50, or 100 fmol) as described under “Experimental Pro-
cedures” (lanes 4–6). Cleavage was also assayed in the presence of RPA (100
fmol) and increasing amounts of Pif1 (25, 50, or 100 fmol) as described under
“Experimental Procedures” (lanes 8–10). The substrate is depicted above the
figure. Asterisk indicates location of radiolabel.
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know whether RPA would inhibit the cleavage of the longer
flaps formed in the presence of Pif1. Synthesis by Pol -wt was
not significantly altered by the addition of both RPA and Pif1
(data not shown). However, in examining the cleavage of dis-
placed flaps in the presence of RPAandPif1, therewas amarked
decrease in long cleavage products, particularly those in the
28–33-nt size range that had been augmented by addition of
Pif1 alone (Fig. 4, lanes 4–6 compared with lanes 8–10, brack-
eted region). These results indicate that Pif1 promotes RPA
inhibition of FEN1.
Evidence that Pif1-stimulated Long Flaps Are a Small Subset
of Total Flaps—Because Pif1 stimulated the creation and cleav-
age of long flaps, we anticipated that Pif1 would also have
increased the overall distance of displacement and cleavage into
the downstream primer region. To test this, reconstitution
assays were performed using the standard-44 substrate, radio-
labeled at the 3-end of the downstream primer to allow visu-
alization of the products remaining after cleavage (Fig. 5). As
strand-displacement proceeds, the 3-labeled cleavage prod-
ucts are expected to become progressively shorter. Following
synthesis by Pol -wt, PCNA, and RFC, there was a distribution
of cleavage product sizes (Fig. 5, lane 3) up to 48 nt into the
downstream primer, at which point the primers should spon-
taneously dissociate. This distribution was consistent with pre-
vious results (11). When increasing amounts of Pif1 were
added, there was no significant change in the distribution of
cleavage products (Fig. 5, lanes 4–6 compared with lane 3).
Moreover, addition of RPA and Pif1 together slightly increased
the amount of cleavage products greater than 20 nt while
decreasing the smallest cleavage products12–13 nt in length
(Fig. 5, lanes 8–10 compared with lanes 4–6). This slight shift
in distribution toward longer products indicates that RPA lim-
its some cleavage by FEN1, as expected from our other results,
and that this limitation is evident in the presence of Pif1. Over-
all, the effects of Pif1 on the cleavage product distribution were
minor, consistent with the conclusion that long flaps promoted
by Pif1 are a small subset of the total population of cleavage
products.
The Presence of RNA on the Downstream Primer Does Not
Inhibit Lengthening of Flaps by Pif1—We considered the possi-
bility that the initiator RNA of every Okazaki fragment would
influence the action of Pif1. We investigated the effects of Pif1
on FEN1 cleavage of a strand-displaced flap when a single ribo-
nucleotide was present at the 5-end of the downstream Oka-
zaki fragment. Although Pif1 does not bind RNA (32, 40), we
expected no change in FEN1 cleavage when RNA initiated the
downstream primer comparedwith when RNAwas absent, as a
single ribonucleotide is unlikely to significantly affect Pif1 bind-
ing to the emerging flap. We designed a substrate, the RNA
substrate, which is identical in sequence to the standard-44
substrate, except it contains a ribonucleotide at the 5-end of
the downstream primer. We performed the same reactions
with the RNA substrate as with the substrate composed only of
DNA (Fig. 6A). Surprisingly, no long products were observed as
increasing amounts of Pif1 were titrated into the reaction with
Pol , PCNA, RFC, and FEN1 (Fig. 6A, lanes 5–8). Examination
of the reaction in which only FEN1 was present, representing
synthesis-independent FEN1 cleavage (Fig. 6A, lane 2),
revealed that the background level of FEN1 cleavage of the ribo-
nucleotide was very high. This is consistent with previous find-
ings from our laboratory demonstrating efficient FEN1 cleav-
age of 5-terminal ribonucleotides (41). FEN1 cleavage
occurred in the absence and presence of an upstream primer,
and also when the upstream primer formed either a nick or a
gap with the downstream primer (41). Therefore, we hypothe-
size that in the current experiment, FEN1 was very efficient at
cleaving off the ribonucleotide before Pol  could begin displac-
ing a flap. Because the downstream primer was radiolabeled at
the 5-end, the majority of FEN1 cleavage removing the ribo-
nucleotide resulted in loss of the radiolabel. Therefore, addi-
tional cleavage of Pol -displaced flaps was not observed. The
radiolabel would be preserved in any flaps that escape FEN1
cleavage. However, in this system, the combination of initial
low abundance and loss of most radiolabel reduced long cleav-
age products to below the level of detection.
Although they may be rare, we wanted to examine the fate of
any RNA-initiated flaps thatmight escape FEN1 cleavage of the
RNA. To address the problem of cleavage of the radiolabeled
RNA, we utilized a substrate with a terminal 2-O-methylated
ribonucleotide, a modification that inhibits RNA cleavage by
FIGURE 5. Pif1-stimulated products are a small subset of cleavage prod-
ucts. The extent of FEN1 cleavage into the downstream primer was assayed
on the standard-44 substrate (U2:T4:D1) in the presence of PCNA/RFC, Pol
-wt, and increasing amounts of Pif1 (25, 50, or 100 fmol) as described under
“Experimental Procedures” (lanes 4–6). Cleavage was also assayed in the
presence of RPA (100 fmol) and increasing amounts of Pif1 (25, 50, or 100
fmol) as described under “Experimental Procedures” (lanes 8–10). The sub-
strate is depicted above the figure. Asterisk indicates location of radiolabel.
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ribonucleases. We hypothesized that the modification would
also inhibit the ability of FEN1 to efficiently cleave off the single
ribonucleotide prior to flap production. Inhibition of FEN1
cleavage preserves the radiolabeled RNA, allowing us to
observe the effects on flap production and cleavage by FEN1 in
the presence of Pif1 andRPA following synthesis. Our substrate
for this experiment was identical to the RNA substrate except
that the single ribonucleotide on the downstream primer was
2-O-methylated. We performed the same experiment as with
the RNA substrate, titrating in increasing amounts of Pif1 to a
reaction with Pol , PCNA, RFC, and FEN1 first without RPA
and then in the presence of RPA (Fig. 6B). As expected, the
amount of synthesis-independent FEN1 cleavage was reduced
with the methylated RNA substrate (Fig. 6B, lane 2). In the
absence of RPA, a population of long flap cleavage products
appeared as the amount of Pif1 increased (Fig. 6B, lanes 5–8).
When RPA was present, these products disappeared (Fig. 6B,
lanes 10–13). We conclude that the ribonucleotide does not
affect the ability of Pif1 to lengthen a flap created by Pol , thus
resulting in formation of long flaps cleavable by FEN1. When
RPA is present, it binds these long flaps and inhibits FEN1
cleavage.
DISCUSSION
We developed a system to reconstitute the reactions of
eukaryotic Okazaki fragment processing in vitro. We have used
it to evaluate two proposed processing pathways of flap
removal, one involving FEN1 as the only nuclease (7–9), and the
other involving the ordered action
of Dna2 and FEN1 (13, 15). The two
nuclease pathways would be
required if flaps become long
enough to bind RPA. The presence
of RPA is expected to inhibit FEN1,
necessitating initial cleavage by
Dna2.
Previous biochemical studies
indicated that primarily short flaps
1–2 nt in length are displaced by Pol
 during RNA primer removal and
cut by FEN1, and the iterative proc-
ess of displacement and cutting is
likely to facilitate primer removal on
the majority of Okazaki fragments
(7–9, 11). Application of our recon-
stituted system in subsequent work
(11), as well as current observations
(Fig. 1), revealed two populations of
FEN1 cleavage products following
displacement by Pol . One is a
sharp peak of products displaced
and cleaved by FEN1 while short,
and the other is a broad, flat distri-
bution of products that reeled out
and became long flaps, 10–36 nt in
length, before cleavage by FEN1.
We hypothesized that in vivo, these
long displaced flaps would be bound
by RPA, effectively preventing FEN1 cleavage. Once bound by
RPA, the long flaps would require Dna2 for cleavage before
FEN1 could cleave, generating a nick that can be ligated.
In the reconstitution assays, we predicted that inclusion of
RPA with Pol  and PCNA/RFC would prevent FEN1 cleavage
of the observed long flaps. Following displacement by Pol -wt,
therewas no apparent effect of RPAon FEN1 cleavage products
(data not shown). This absence of inhibition could have been
anticipated because observed long flaps cleaved in the presence
of Pol -wtwere 10–20 nt, too small for stable RPAbinding that
occurs at a length of 30 nt (33). This result is also consistent
with the small levels of RPA inhibition of FEN1 cleavage on a
19-nt fixed double-flap (Fig. 3).
The exonuclease-deficient Pol -01 generated longer flap
cleavage products (8, 9, 11), up to 36 nt (Fig. 1). Flaps of this
length, which are readily observable with Pol -01, should sta-
bly bind RPA, thus inhibiting FEN1 cleavage. Surprisingly,
however, in the presence of Pol -01, PCNA/RFC, and FEN1,
RPA only moderately inhibited the formation of the long cleav-
age products (Fig. 2). The longest cleavage products in the
28–37-nt size range weremost sensitive to RPA inhibition (Fig.
2), which is consistent with the fixed flap results showing
greater levels of inhibition with the 28- and 37-nt double-flaps
compared with the 19-nt flap (Fig. 3).
Because RPA was a highly effective inhibitor of FEN1 cleav-
age on long fixed flaps, we expected inhibition to be similar on
long strand-displaced flaps. An advantage of the system that we
have employed is that it allowed us to make this important
FIGURE 6. RNA does not inhibit lengthening of flaps by Pif1 during synthesis of Okazaki fragments. A,
initial cleavage by FEN1 was assayed on the RNA substrate (U2:T4:D2) in the presence of PCNA/RFC, Pol -wt,
and increasing amounts of Pif1 (25, 50, 100, or 200 fmol) as described under “Experimental Procedures” (lanes
5–8). Cleavage was also assayed in the presence of RPA (100 fmol) and increasing amounts of Pif1 (25, 50, 100,
or 200 fmol) as described under “Experimental Procedures” (lanes 10–13). The substrate is depicted above the
figure. Thegray segment represents the ribonucleotide. Theasterisk indicates locationof radiolabel.B, the same
reactions as in A except the substrate used was the methylated substrate (U2:T4:D3). The substrate is depicted
above the figure. The gray circle represents the 2-O-methylated ribonucleotide. The asterisk indicates the
location of radiolabel.
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comparison. In actuality, moderate inhibition of FEN1 cleavage
by RPA in the context of dynamically lengthening flaps is in
obvious contrast with RPA inhibition on fixed flaps. FEN1
cleavage assays on fixed double-flaps revealed more than
90% inhibition on 28- and 37-nt flaps (Fig. 3A and B) com-
pared with only 36% inhibition on cleavage products greater
than 28 nt when cleavage occurs during displacement (Fig.
2). These results indicate an inherent difference in the ability
of RPA to inhibit FEN1 cleavage when the flap is preformed
and fixed versus when flaps are lengthening during strand-
displacement. In the displacement assays, the moderate RPA
inhibition of long flap cleavage suggests that when flaps are
created dynamically, there is a competition between RPA
and FEN1 for binding to the flap favoring FEN1. Moreover,
assessment of competition on a fixed flap when the RPA was
added before, with, or after the FEN1, indicates that initial
binding of FEN1 thwarts the inhibitory ability of RPA (Fig.
3C). We propose that by the time most flaps become long
enough to bind RPA, FEN1 has already recognized their
5-ends and begun tracking (Fig. 7A). We envision FEN1
molecules tracking near the base of the elongating flap, rac-
ing the displacement process to eventually reach the cleav-
age site. FEN1 may achieve this binding advantage because it
is already a stable part of the lagging strand maturation com-
plex. This would position it on the flap at the earliest time of
strand displacement. Alternatively, FEN1 may simply have
the ability to bind and track on nearly every elongating flap
before it becomes long enough to form a stable complex with
the RPA. In either case, RPA molecules would then bind
behind the FEN1, too late to inhibit cleavage.
This current biochemical data
prompted a re-evaluation of the
pathways of primer removal during
Okazaki fragment maturation, spe-
cifically of the role of RPA in direct-
ing flaps into the two-nuclease
pathway. Inhibition of FEN1 cleav-
age by RPAbinding of long flapswas
proposed to be the key reason for
use of the two-nuclease pathway
(13, 15). Yet, the results presented
here demonstrate that even in the
presence of RPA, FEN1 cleavage of
displaced flaps is only moderately
inhibited by RPA (Fig. 2). Is it possi-
ble that the two-nuclease pathway is
either completely redundant or vir-
tually never used?
Recent genetic results in S. cerevi-
siae suggest the involvement of
another factor, the Pif1 helicase, in
directing flaps to the two-nuclease
pathway. The lethality of dna2
mutation is suppressed by pif1
(22). Studies in S. pombe indicate a
similar relationship between the
Pif1 ortholog Pfh1 and Dna2,
because mutations in pfh1 suppress
the temperature-sensitive phenotype of dna2 mutations (27).
These genetic results imply that the Pif1 helicase creates a need
for Dna2, possibly by promoting long flap formation (22, 27),
and indicate a role for Pif1 in Okazaki fragment processing.
Results presented here support this hypothesis. The addition of
Pif1 to the Okazaki fragment processing system promoted the
appearance of long FEN1 cleavage products (Fig. 4). Pif1 nota-
bly increased products in the 28–33-nt size range. It appears
that Pif1 accelerated flap displacement, allowing flaps to
become longer before FEN1 cleavage could occur (Fig. 7B). Yet,
the Pif1-stimulated products were a small subset of FEN1 prod-
ucts, because addition of Pif1 only mildly stimulated the
amount of synthesis (data not shown) and did not notably affect
the extent of cleavage into the downstream primer (Fig. 5).
Although these long Pif1-stimulated products were not abun-
dant in our system, the actual numbers in vivo would be signif-
icant becausemillions of Okazaki fragments are processed dur-
ing synthesis in a replication cycle.
Our observations that Pif1 stimulates long flap cleavage by
FEN1 (Fig. 4) and that RPA only moderately inhibits FEN1
cleavage of long flaps (Fig. 2) prompted the question of whether
Pif1 is the critical additional component that necessitates the
Dna2-requiring pathway. Pif1-stimulated flaps in the 28–33-nt
size range are long enough to bind RPA (33). Correspondingly,
RPA did effectively inhibit FEN1 cleavage of this size range of
flaps created in the presence of Pif1 (Fig. 4). This result suggests
that Pif1 increases the rate of flap displacement, such that FEN1
takes longer to track to the base of the flap for cleavage. Signif-
icantly, Pif1 appears to promote such rapid flap formation that
RPA is able to bind to the flap ahead of the tracking FEN1
FIGURE 7. Pif1 directs long flaps toward the two-nuclease pathway for primer removal. A, in most cases
FEN1 is tracking near the base of the elongating flap, racing the displacement process to eventually reach the
site of cleavage. Most RPAmolecules would then bind behind the FEN1, too late to prevent cleavage (refer to
Fig. 2, lanes 3–6). B, Pif1 promotes flap displacement, allowing some flaps to become long before FEN1 cleav-
age occurs (refer to Fig. 4, lanes 3–6). C, Pif1 increases the rate of flap formation such that FEN1molecules take
longer to track to the flap base for cleavage. In the presence of RPA, the flap canbind RPA aheadof the tracking
FEN1. RPA bound in this position can prevent FEN1 cleavage (refer to Fig. 4, lanes 7–10).
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(Fig. 7C). With Pif1, RPA binding prevents cleavage of a signif-
icant number of flaps by FEN1 alone and necessitates cleavage
via the two-nuclease pathway (13).
Okazaki fragments in vivo are initiated by RNA, made by Pol
, whichmust be removed. Removal of only the ribonucleotides
is not sufficient tomaintain high replication fidelity because Pol
 lacks a 3-5 proofreading activity, and some of the DNA
nucleotides incorporated by Pol  just beyond the RNAmay be
erroneous (42). As a result, additional flap displacement and
cleavage of the downstream Okazaki fragment is necessary to
remove the DNA synthesized by Pol  (29, 43). Consequently,
we were interested in the effect of Pif1 on flap formation with
substrates that more closely resemble the natural RNA-primed
Okazaki fragment (2, 29). Therefore, we felt it was reasonable to
test a model fragment with a single initiator ribonucleotide.
In the first experiments, FEN1 was so efficient at removing
the labeled ribonucleotide of the downstream primer that long
FEN1 cleavage products were virtually undetectable (Fig. 6A).
This result supports the validity of our results with full DNA
fragments, because the RNA of nearly all fragments is likely to
have been removed in vivo before the flaps could achieve signif-
icant length. To determine the effects of any fragments that
escaped complete RNA removal by FEN1, we designed and
used a downstream primer with a 2 O-methylated 5-ribonu-
cleotide (Fig. 6B). As with the substrates containing only DNA,
we found that Pif1 promoted RPA inhibition of FEN1 cleavage.
This result further verifies that the DNA-initiated substrates
served as a sufficient representative substrate for the RNA-ini-
tiated Okazaki fragments, consistent with previous work (11).
Moreover, in helicase assays, Pfh1 from S. pombe was equally
active on RNA- and DNA-initiated flaps, suggesting that Pif1
helicases are active in vitro on substrates that are relevant
in vivo (27).
Supporting previous genetic data (22), our biochemical
results reveal a role for Pif1 in eukaryotic cellular Okazaki frag-
ment maturation to remove the initiator RNA primer, specifi-
cally in the processing of long flaps. Results with our model
reconstitution system show that once the Pol  strand displaces
the downstream primer, FEN1 can track onto the flap and
cleave at its base (Fig. 7A). The dynamics of flap formation do
not allow RPA to bind quickly enough to inhibit FEN1. Pif1
accelerates flap formation allowing the flaps to achieve greater
lengths before FEN1 cleavage (Fig. 7B). However, when RPA is
present with Pif1 and FEN1, flap growth is sufficiently rapid
that RPA can bind and block FEN1 cleavage (Fig. 7C). Because
Pif1 is unable to bind RNA (32, 40), Pif1 involvement in
unwinding the downstreamOkazaki fragment necessitates that
Pol  displaces whatever remains of the RNA primer (2) before
Pif1 can bind to the flap and aid displacement. However, our
results indicate that the presence of the initiator RNA does not
alter the fundamental role of Pif1. The biological implication is
that by promoting RPA inhibition of FEN1 cleavage, Pif1 is
directing flaps toward the two-nuclease cleavage pathway,
requiring Dna2 cleavage for primer removal. Examining the
influence of Pif1 on flap cleavage by Dna2 in the context of
strand-displacement will be an important next step to further
elucidate the role of Pif1 in replication. Additional experiments
will be necessary to expandour understanding of the conditions
that determine which of the cleavage pathways is followed for
primer removal during Okazaki fragment maturation.
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